Skip to content

AI in Outpatient Practice for Diagnosing Aortic Stenosis and Diastolic Dysfunction

The Clinical Utility of Artificial Intelligence-enabled Electrocardiograms in the Outpatient Practice - Diagnosing Aortic Stenosis and Diastolic Dysfunction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06580158
Enrollment
2000
Registered
2024-08-30
Start date
2024-11-08
Completion date
2027-03-01
Last updated
2026-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aortic Stenosis, Diastolic Dysfunction

Brief summary

Two recently developed artificial intelligence-enabled electrocardiogram (AI-ECG) models have been developed to detect aortic stenosis (AS) and diastolic dysfunction (DD). AI-ECG for AS has a sensitivity of 78% and specificity of 74%, and AI-ECG for DD has a sensitivity of 83% and specificity of 80%. However, these models have never been prospectively applied to diagnose AS or DD, which may be useful for patients and providers from a diagnostic and prognostic perspective and especially in settings where access to higher- level medical care is limited. In this study, we aim to determine the clinical utility of these AI-ECG models by prospectively applying them to an outpatient cohort and then completing a focused point-of-care ultrasound to evaluate those who are AI-ECG positive for AS and DD.

Interventions

DEVICEAI-ECG Dashboard

Patients standard of care ECG's will be processed through the AI-ECG Dashboard

DIAGNOSTIC_TESTPoint of care ultrasound (POCUS)

Patients will undergo a ultrasound to confirm diagnosis of atrial stenosis or diastolic dysfunction.

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 60 years of age must have a clinical scheduled ECG performed.

Exclusion criteria

* \< 59 years of age * Is not scheduled for a clinical ECG * Unable to provide consent.

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with positive AI-ECGBaselinePositive AI-ECG will be determined by the sensitivity, specificity, positive predictive value, and negative predictive value.
Number of studies with reasonable image quality in patients with positive AI-ECGBaselineImage quality will be determined by sonographers at the time of imaging and will be scored on a scale from 1-4: 1. Excellent , sufficient for publication 2. Good, sufficient for data analysis 3. Fair, just enough for data analysis without complete views 4. Poor, not usable for data analysis

Secondary

MeasureTime frameDescription
Number of times the AI ECG and TTE (transthoracic echocardiogram) are statistically comparativeBaselineWill be compared using parametric (2-sample t-test) and non-parametric tests (Wilcoxon rank sum test) for continuous variables, and the χ2 test or Fisher exact test for nominal variables. A p-value of \< 0.05 will be categorized as significant for the statistical analysis

Countries

United States

Contacts

CONTACTBrian Rudquist
Rudquist.Brian@mayo.edu(507) 538-5146
CONTACTJae Oh, M.D.
oh.jae@mayo.edu
PRINCIPAL_INVESTIGATORJae Oh, M.D.

Mayo Clinic

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026